Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Chappuy

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The American Journal of Drug and Alcohol Abuse|February 25, 2025
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorderOlivier Lejeune, Mathieu Chappuy, François Bailly, et al.
Archives of Sexual Behavior|March 5, 2026
Prevalence and Factors Associated with Sexual Addiction in Men Who Have Sex with Men Seeking Treatment for Problematic Chemsex: Findings from the CHAMELEON Cross-Sectional StudyFrédéric Buathier, Philippe Lack, Mathieu Chappuy, et al.
Therapie|June 5, 2020
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice]Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Therapie|June 6, 2020
Prolonged-release buprenorphine formulations: Perspectives for clinical practiceMathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
The International Journal on Drug Policy|June 15, 2024
Comparing methadone policy and practice in France and the US: Implications for US policy reformHonora Englander, Mathieu Chappuy, Noa Krawczyck, et al.
Pain and Therapy|June 29, 2026
French National Guidelines for the Appropriate Use of Opioids: Analgesia, Opioid Use Disorder, and Overdose Prevention-Part 2: Prevention and Management of Opioid Use Disorder and OverdoseCélian Bertin, Julie Dupouy, Nicolas Authier, et al.
The International Journal on Drug Policy|November 24, 2024
National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020-2022Julia de Ternay, Claire Meley, Patrick Guerin, et al.
Therapie|January 28, 2022
Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016-2020Mathieu Chappuy, Lotfi Fezzani, Delphine Ragonnet, et al.
Pain and Therapy|June 29, 2026
French National Guidelines for the Appropriate Use of Opioids: Analgesia, Opioid Use Disorder, and Overdose Prevention-Part 1: Methodology and Pain ManagementCélian Bertin, Julie Dupouy, Nicolas Authier, et al.
Fundamental & Clinical Pharmacology|September 9, 2021
Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021Mathieu Chappuy, Mikail Nourredine, Bertrand Clerc, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The American Journal of Drug and Alcohol Abuse|February 25, 2025
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorderOlivier Lejeune, Mathieu Chappuy, François Bailly, et al.
Archives of Sexual Behavior|March 5, 2026
Prevalence and Factors Associated with Sexual Addiction in Men Who Have Sex with Men Seeking Treatment for Problematic Chemsex: Findings from the CHAMELEON Cross-Sectional StudyFrédéric Buathier, Philippe Lack, Mathieu Chappuy, et al.
Therapie|June 5, 2020
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice]Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Therapie|June 6, 2020
Prolonged-release buprenorphine formulations: Perspectives for clinical practiceMathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
The International Journal on Drug Policy|June 15, 2024
Comparing methadone policy and practice in France and the US: Implications for US policy reformHonora Englander, Mathieu Chappuy, Noa Krawczyck, et al.
Pain and Therapy|June 29, 2026
French National Guidelines for the Appropriate Use of Opioids: Analgesia, Opioid Use Disorder, and Overdose Prevention-Part 2: Prevention and Management of Opioid Use Disorder and OverdoseCélian Bertin, Julie Dupouy, Nicolas Authier, et al.
The International Journal on Drug Policy|November 24, 2024
National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020-2022Julia de Ternay, Claire Meley, Patrick Guerin, et al.
Therapie|January 28, 2022
Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016-2020Mathieu Chappuy, Lotfi Fezzani, Delphine Ragonnet, et al.
Pain and Therapy|June 29, 2026
French National Guidelines for the Appropriate Use of Opioids: Analgesia, Opioid Use Disorder, and Overdose Prevention-Part 1: Methodology and Pain ManagementCélian Bertin, Julie Dupouy, Nicolas Authier, et al.
Fundamental & Clinical Pharmacology|September 9, 2021
Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021Mathieu Chappuy, Mikail Nourredine, Bertrand Clerc, et al.
Pageof 2